Review



anti moxd1 antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Bioss anti moxd1 antibody
    (a) Pearson correlation between <t>MOXD1</t> expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Anti Moxd1 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti moxd1 antibody/product/Bioss
    Average 94 stars, based on 3 article reviews
    anti moxd1 antibody - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer"

    Article Title: The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer

    Journal: Open Medicine

    doi: 10.1515/med-2025-1271

    (a) Pearson correlation between MOXD1 expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Figure Legend Snippet: (a) Pearson correlation between MOXD1 expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Techniques Used: Expressing, Biomarker Discovery, Quantitative Proteomics

    (a) Heatmap showing the correlations between MOXD1 expression and the ESTIMATE score, stromal score, immune score, tumor purity, TIDE, and EMT score. (b) Immune infiltration in the high- and low- MOXD1 expression groups in the training cohort (using the ssGSEA algorithm). (c) Immune infiltration in the high- and low- MOXD1 expression groups in the training cohort (using the CIBERSORT algorithm). (d) and (e) Location of MOXD1 expression in the STAD- GSE167297 and STAD- GSE134520 datasets.
    Figure Legend Snippet: (a) Heatmap showing the correlations between MOXD1 expression and the ESTIMATE score, stromal score, immune score, tumor purity, TIDE, and EMT score. (b) Immune infiltration in the high- and low- MOXD1 expression groups in the training cohort (using the ssGSEA algorithm). (c) Immune infiltration in the high- and low- MOXD1 expression groups in the training cohort (using the CIBERSORT algorithm). (d) and (e) Location of MOXD1 expression in the STAD- GSE167297 and STAD- GSE134520 datasets.

    Techniques Used: Expressing

    (a) GO analysis of MOXD1 . (b) KEGG analysis of MOXD1 . (c) PPI network analysis of MOXD1. (d) GSEA of MOXD1 .
    Figure Legend Snippet: (a) GO analysis of MOXD1 . (b) KEGG analysis of MOXD1 . (c) PPI network analysis of MOXD1. (d) GSEA of MOXD1 .

    Techniques Used:

    (a) Association between MOXD1 mRNA expression levels and molecular classification in the TCGA-STAD cohort. (b) Association between MOXD1 mRNA expression levels and chemotherapy sensitivity in the training cohort.
    Figure Legend Snippet: (a) Association between MOXD1 mRNA expression levels and molecular classification in the TCGA-STAD cohort. (b) Association between MOXD1 mRNA expression levels and chemotherapy sensitivity in the training cohort.

    Techniques Used: Expressing

    (a)–(c) IHC staining of TMAs for MOXD1 (well-differentiated, moderately differentiated, and poorly differentiated). (d) K‒M survival curve for MOXD1 expression in TMAs. (e) Nomogram constructed using MOXD1 expression and the metastatic lymph node ratio in TMAs. (f) K‒M survival curve for the nomogram. (g) timeROC curve for the nomogram. (h) DCA curve for the nomogram. (i) Calibration curve for the nomogram.
    Figure Legend Snippet: (a)–(c) IHC staining of TMAs for MOXD1 (well-differentiated, moderately differentiated, and poorly differentiated). (d) K‒M survival curve for MOXD1 expression in TMAs. (e) Nomogram constructed using MOXD1 expression and the metastatic lymph node ratio in TMAs. (f) K‒M survival curve for the nomogram. (g) timeROC curve for the nomogram. (h) DCA curve for the nomogram. (i) Calibration curve for the nomogram.

    Techniques Used: Immunohistochemistry, Expressing, Construct



    Similar Products

    anti moxd1 antibody  (Bioss)
    94
    Bioss anti moxd1 antibody
    (a) Pearson correlation between <t>MOXD1</t> expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Anti Moxd1 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti moxd1 antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    anti moxd1 antibody - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    anti moxd1  (Bioss)
    94
    Bioss anti moxd1
    (a) Pearson correlation between <t>MOXD1</t> expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Anti Moxd1, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti moxd1/product/Bioss
    Average 94 stars, based on 1 article reviews
    anti moxd1 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    moxd1 polyclonal antibody  (Bioss)
    94
    Bioss moxd1 polyclonal antibody
    (a) Pearson correlation between <t>MOXD1</t> expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Moxd1 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/moxd1 polyclonal antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    moxd1 polyclonal antibody - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    moxd1  (Bioss)
    94
    Bioss moxd1
    (a) Pearson correlation between <t>MOXD1</t> expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Moxd1, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/moxd1/product/Bioss
    Average 94 stars, based on 1 article reviews
    moxd1 - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (a) Pearson correlation between MOXD1 expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: Open Medicine

    Article Title: The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer

    doi: 10.1515/med-2025-1271

    Figure Lengend Snippet: (a) Pearson correlation between MOXD1 expression and the OS risk score in the training cohort. (b) K‒M survival curve for MOXD1 expression in the training cohort. (c) K‒M survival curve for MOXD1 expression in the validation cohort. (d) Differential expression of MOXD1 between tumor and paratumorous normal tissue. (e–g) Differential expression of MOXD1 in the T, N, and pTNM stages. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Next, a diluted anti-MOXD1 antibody (Bioss, bs-17733R; 1:150) was added, and the TMAs were then incubated overnight at 4°C.

    Techniques: Expressing, Biomarker Discovery, Quantitative Proteomics

    (a) Heatmap showing the correlations between MOXD1 expression and the ESTIMATE score, stromal score, immune score, tumor purity, TIDE, and EMT score. (b) Immune infiltration in the high- and low- MOXD1 expression groups in the training cohort (using the ssGSEA algorithm). (c) Immune infiltration in the high- and low- MOXD1 expression groups in the training cohort (using the CIBERSORT algorithm). (d) and (e) Location of MOXD1 expression in the STAD- GSE167297 and STAD- GSE134520 datasets.

    Journal: Open Medicine

    Article Title: The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer

    doi: 10.1515/med-2025-1271

    Figure Lengend Snippet: (a) Heatmap showing the correlations between MOXD1 expression and the ESTIMATE score, stromal score, immune score, tumor purity, TIDE, and EMT score. (b) Immune infiltration in the high- and low- MOXD1 expression groups in the training cohort (using the ssGSEA algorithm). (c) Immune infiltration in the high- and low- MOXD1 expression groups in the training cohort (using the CIBERSORT algorithm). (d) and (e) Location of MOXD1 expression in the STAD- GSE167297 and STAD- GSE134520 datasets.

    Article Snippet: Next, a diluted anti-MOXD1 antibody (Bioss, bs-17733R; 1:150) was added, and the TMAs were then incubated overnight at 4°C.

    Techniques: Expressing

    (a) GO analysis of MOXD1 . (b) KEGG analysis of MOXD1 . (c) PPI network analysis of MOXD1. (d) GSEA of MOXD1 .

    Journal: Open Medicine

    Article Title: The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer

    doi: 10.1515/med-2025-1271

    Figure Lengend Snippet: (a) GO analysis of MOXD1 . (b) KEGG analysis of MOXD1 . (c) PPI network analysis of MOXD1. (d) GSEA of MOXD1 .

    Article Snippet: Next, a diluted anti-MOXD1 antibody (Bioss, bs-17733R; 1:150) was added, and the TMAs were then incubated overnight at 4°C.

    Techniques:

    (a) Association between MOXD1 mRNA expression levels and molecular classification in the TCGA-STAD cohort. (b) Association between MOXD1 mRNA expression levels and chemotherapy sensitivity in the training cohort.

    Journal: Open Medicine

    Article Title: The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer

    doi: 10.1515/med-2025-1271

    Figure Lengend Snippet: (a) Association between MOXD1 mRNA expression levels and molecular classification in the TCGA-STAD cohort. (b) Association between MOXD1 mRNA expression levels and chemotherapy sensitivity in the training cohort.

    Article Snippet: Next, a diluted anti-MOXD1 antibody (Bioss, bs-17733R; 1:150) was added, and the TMAs were then incubated overnight at 4°C.

    Techniques: Expressing

    (a)–(c) IHC staining of TMAs for MOXD1 (well-differentiated, moderately differentiated, and poorly differentiated). (d) K‒M survival curve for MOXD1 expression in TMAs. (e) Nomogram constructed using MOXD1 expression and the metastatic lymph node ratio in TMAs. (f) K‒M survival curve for the nomogram. (g) timeROC curve for the nomogram. (h) DCA curve for the nomogram. (i) Calibration curve for the nomogram.

    Journal: Open Medicine

    Article Title: The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer

    doi: 10.1515/med-2025-1271

    Figure Lengend Snippet: (a)–(c) IHC staining of TMAs for MOXD1 (well-differentiated, moderately differentiated, and poorly differentiated). (d) K‒M survival curve for MOXD1 expression in TMAs. (e) Nomogram constructed using MOXD1 expression and the metastatic lymph node ratio in TMAs. (f) K‒M survival curve for the nomogram. (g) timeROC curve for the nomogram. (h) DCA curve for the nomogram. (i) Calibration curve for the nomogram.

    Article Snippet: Next, a diluted anti-MOXD1 antibody (Bioss, bs-17733R; 1:150) was added, and the TMAs were then incubated overnight at 4°C.

    Techniques: Immunohistochemistry, Expressing, Construct